Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Metastatic Prostate Cancer: Sorting Through the Treatment Maze – The ASCO Post

ascopost.com - Neal Shore, MD, FACS The message still needs to get out that metastatic castration-sensitive prostate cancer should be treated with both androgen-deprivation therapy (ADT) and either docetaxel or an androgen receptor pathway inhibitor. In spite of “overwhelming” support for ADT plus abiraterone/prednisone,...

Read the full article here

Related Content